Advocacy at a Glance STEVEN GROSSMAN 6/4/21 Advocacy at a Glance STEVEN GROSSMAN 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 6/4/21 Advocacy at a Glance STEVEN GROSSMAN 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More
Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
